PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

Patients with chemo-refractory metastatic colorectal cancer (mCRC) have poor prognoses. The application of programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors encouragingly improved the survival of mCRC patients with microsatellite instability-high (MSI-H)/mismat...

Full description

Bibliographic Details
Main Authors: Jiabao Yang, Pengfei Xing, Yuehong Kong, Meiling Xu, Liyuan Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
colorectal cancer
immunotherapy
radiotherapy
GM-CSF
MSS/pMMR
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1078915/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1078915/full

Similar Items